Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetics of a New Paediatric Formulation of Valacyclovir Used for Prophylaxis and Treatment of Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV) Infections in Children, Phase II (VALID II)

Next Previous
Search
Trial Profile

Pharmacokinetics of a New Paediatric Formulation of Valacyclovir Used for Prophylaxis and Treatment of Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV) Infections in Children, Phase II (VALID II)

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 10 Feb 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Valaciclovir (Primary)
  • Indications Herpes simplex virus infections; Varicella zoster virus infections
  • Focus Pharmacokinetics
  • Acronyms VALID II

    • Most Recent Events

    • 07 Jun 2021 Status changed from recruiting to discontinued although interim analysis showed positive results. It was difficult to include patients and also the fact that the grant for this project has ended, the company have decided to complete the study before. The company had included the total number of 16 patients.
    • 08 Oct 2020 Planned End Date changed from 30 Nov 2020 to 30 Nov 2021.
    • 08 Oct 2020 Planned primary completion date changed from 1 Sep 2020 to 1 Sep 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top